Product Benefits

The FRED® device is the first flow diverter in the U.S. to use a self-expanding braided nitinol mesh to help re-direct blood flow and promote aneurysm occlusion. The unique interwoven nitinol design of the FRED® device allows for smooth delivery to the target aneurysm, as well as reliable opening and vessel wall apposition, resulting in high treatment durability. 

 

The FRED® device has been CE marked since 2013, safely used in nearly 20,000 procedures, and published in numerous clinical studies around the world. The FRED® device pivotal study adds new evidence to the large existing body of global clinical data, further demonstrating the safety and effectiveness of the device.

 

 

  • Innovative and elegant device design results in easy device sizing, deployment, and device opening

  • Consistent device opening and ability to recapture and reposition for precise placement

  • Dual action design provides vessel wall stability and conformance for effective flow diversion

*The blue wire denotes the radiopaque stent body material that integrates both stent layers

*The blue wire denotes the radiopaque stent body material that integrates both stent layers

Specifications

Product Compatibility:

The FRED® device is available in both 27 and 21 systems depending on implant diameter. The FRED 27 system is delivered through the 0.027” Headway® 27 Microcatheter. The FRED® 21 system is designed to be delivered through the 0.021” Headway® 21 Microcatheter. The SOFIA® family of catheters can be used for tri-axial support.

Learn More

Aneurysm Therapy

Learn more about MicroVention's groundbreaking disease treatments.

Learn More

Clinical Education

Find clinical trials, studies and registries involving this product. Visit clinicaltrials.gov for more information.

Learn More

How to Order

Visit our contact page for information on how to place an order by phone, fax or email.

Learn More

TITLE

ADDRESS_TEXT

    PHONE LIST